Strides Shasun has announced plans to sell Shasun Pharma to its current management, a provider of contract research and manufacturing services in the UK.
The sale consideration is expected to be approximately $36m and will be completed by September 2016.
Shanghai Fosun Pharma has announced a non-binding proposal to acquire Gland Pharma for a purchase consideration ranging between $1bn and $1.5bn.
The company expects that the acquisition will help develop its drug manufacturing and research and development (R&D) capacity.
Image: Shanghai Fosun Pharma expects that the acquisition will help develop its drug manufacturing and research and development (R&D) capacity. Photo: Courtesy of Shanghai Fosun Pharma.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData